Yvonne Körner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yvonne Körner has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Doris Haja
2 shared publicationsWerner Cassel
2 shared publicationsCharlotte Meindorfner
Lehrstuhl für Psychologie III der Bayerischen Julius-Maximilians-Universität Würzburg
1 shared publicationCharlotte Meindorfner Msc
Center for Traffic Sciences, Department of Psychology, University of Wuerzburg, Wuerzburg, Germany
1 shared publicationEva Schnabel
1 shared publicationHans-Peter Kruger
Lehrstuhl für Psychologie III der Bayerischen Julius-Maximilians-Universität Würzburg
1 shared publication
Latest Publications
- 3 April 2007
- Published by Springer Nature
- p. 269-280
Drogen und Opiate im Straßenverkehr
- 20 May 2004
- Published by Wiley in Movement Disorders
- Vol. 19 (11) , 1298-1305
Predictors of sudden onset of sleep in Parkinson's disease
With respect to the ongoing discussion of “sleep attacks” in Parkinson's disease (PD), we sought to estimate the prevalence of sudden onset of sleep (SOS) with and without preceding sleepiness in PD, to identify associated factors, and to define the role of antiparkinsonian medication in SOS. We sent a questionnaire about SOS, sleep behaviour, and medication to 12,000 PD patients. The response rate was 63%, from which 6,620 complete data sets could be analysed. A total of 42.9% of our population reported SOS, 10% of whom never experienced sleepiness before the appearance of SOS (4.3% of all), and we identified the administration of all dopaminergic drugs as a risk factor for SOS. However, SOS occurred earlier after introduction of nonergoline dopamine agonists (DA) and was more strongly associated with nonergoline DA in younger patients (below 70 years) with a shorter disease duration (up to 7 years) but, actually, medication was less efficient in predicting SOS than most other factors considered such as higher age, male sex, longer disease duration, and the report of sleep disturbances. This survey strongly suggests that SOS is a multifactorial phenomenon. Some subgroups are at particular risk of experiencing SOS under nonergoline DA, especially at the beginning of this therapy. Our results support the current notion that SOS, in part, can be attributed to PD‐specific pathology because disease duration and subjective disease severity have been shown to be predictors of SOS. We recommend the development of a standardised question to recognise SOS and to facilitate the comparison of prevalence estimates. © 2004 Movement Disorder Society
- 20 May 2004
- Published by Wiley in Movement Disorders
- Vol. 19 (11) , 1298-1305
Predictors of sudden onset of sleep in Parkinson's disease
With respect to the ongoing discussion of “sleep attacks” in Parkinson's disease (PD), we sought to estimate the prevalence of sudden onset of sleep (SOS) with and without preceding sleepiness in PD, to identify associated factors, and to define the role of antiparkinsonian medication in SOS. We sent a questionnaire about SOS, sleep behaviour, and medication to 12,000 PD patients. The response rate was 63%, from which 6,620 complete data sets could be analysed. A total of 42.9% of our population reported SOS, 10% of whom never experienced sleepiness before the appearance of SOS (4.3% of all), and we identified the administration of all dopaminergic drugs as a risk factor for SOS. However, SOS occurred earlier after introduction of nonergoline dopamine agonists (DA) and was more strongly associated with nonergoline DA in younger patients (below 70 years) with a shorter disease duration (up to 7 years) but, actually, medication was less efficient in predicting SOS than most other factors considered such as higher age, male sex, longer disease duration, and the report of sleep disturbances. This survey strongly suggests that SOS is a multifactorial phenomenon. Some subgroups are at particular risk of experiencing SOS under nonergoline DA, especially at the beginning of this therapy. Our results support the current notion that SOS, in part, can be attributed to PD‐specific pathology because disease duration and subjective disease severity have been shown to be predictors of SOS. We recommend the development of a standardised question to recognise SOS and to facilitate the comparison of prevalence estimates. © 2004 Movement Disorder Society
- 1 August 2003
- Published by Springer Nature in Somnologie
- Vol. 7 (3) , 79-88
Zusammenhang zwischen selbstberichteter Tagesmudigkeit und selbstberichteten Schlafstorungen vor und nach einer Erkrankung an M. Parkinson - Fragebogendaten von 6620 Parkinson-Patienten. Correlation of Self-Reported Daytime Sleepiness and Self-Reported Sleep Disorders Before and After the Onset of Parkinson's Disease (PD) - Data from a Questionnaire Survey of 6,620 PD Patients
- 1 August 2003
- Published by Springer Nature in Somnologie
- Vol. 7 (3) , 79-88
Zusammenhang zwischen selbstberichteter Tagesmudigkeit und selbstberichteten Schlafstorungen vor und nach einer Erkrankung an M. Parkinson - Fragebogendaten von 6620 Parkinson-Patienten. Correlation of Self-Reported Daytime Sleepiness and Self-Reported Sleep Disorders Before and After the Onset of Parkinson's Disease (PD) - Data from a Questionnaire Survey of 6,620 PD Patients